Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ||
Founding Date | Founding Date 1996 | Founding Date 2002 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Gainesville, US HQ Gainesville, US San Diego, US |
Employees | Employees 2081% increase | Employees 58415% increase | Employees 21316% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.4 b | Valuation ($) 116.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $399.4m (FY, 2023) | Revenue (est.) $94.6m (FY, 2023) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $37.3m (FY, 2023) | Cost of goods $76.5m (FY, 2023) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $362m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income ($151.6m) (FY, 2023) | Net income ($13.3m) (FY, 2023) |